Who
Sarah Nemec
Senior VP, Finance and PAO
Company insider
Files Form 4 as: Senior VP, Finance and PAO, Bolt Biotherapeutics.
In numbers
- Trades disclosed
- 37
- Buys
- 5
- Sells
- 3
- Bought
- $8,636
- Sold
- $52K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Jun 2024
- Last trade
- 18 Sep 2026
- Last filed
- 21 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 21 Sep 2026 | BOLT Bolt BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $13K4,077 at $3.24 | filing |
| 18 Sep 2026filed 21 Sep 2026 | BOLT Bolt BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $13K4,077 at $3.24 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BOLT Bolt BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $9,6962,922 at $3.32 | filing |
| 17 Sep 2026filed 21 Sep 2026 | BOLT Bolt BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $9,7012,922 at $3.32 | filing |
| 16 Sep 2026filed 21 Sep 2026 | BOLT Bolt BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $3,181843 at $3.77 | filing |
| 16 Sep 2026filed 21 Sep 2026 | BOLT Bolt BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $3,178843 at $3.77 | filing |
| 5 Jun 2026filed 21 Sep 2026 | BOLT Bolt BiotherapeuticsBiotechnology | SEC FORM 4 Bought | $1,973509 at $3.88 | filing |
| 5 Jun 2026filed 21 Sep 2026 | BOLT Bolt BiotherapeuticsBiotechnology | SEC FORM 4 Bought | $1,975509 at $3.88 | filing |
| 28 Jan 2026filed 4 Feb 2026 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 28 Jan 2026filed 4 Feb 2026 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,236 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,236 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —375 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —375 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —600 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —600 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,199 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,199 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,699 | filing |
| 12 Dec 2025filed 16 Dec 2025 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —6,699 | filing |
News
Bolt Biotherapeutics (NASDAQ:BOLT) and Applied Dna Sciences (NASDAQ:BNBX) Head-To-Head ReviewBOLT · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Sarah Nemec; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.